XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.22.1

Income Per Share and Stockholders' Equity | 3 Months Ended
--- | ---
Mar. 31, 2022
Earnings Per Share And Stockholders Equity [Abstract] |
Income Per Share and Stockholders' Equity | Income Per Share and Stockholders' Equity The calculations of basic and diluted income per share attributable to CBRE Group, Inc. stockholders are as follows (dollars in thousands, except share and per share data):
| Three Months Ended March 31, |  |
| 2022 |  | 2021 |  |  |  |
Basic Income Per Share |  |  |  |  |  |  |
Net income attributable to CBRE Group, Inc. stockholders | $ | 392,297 |  |  | $ | 266,202 |  |  |  |  |
Weighted average shares outstanding for basic income per share | 331,925,104 |  |  | 335,860,494 |  |  |  |  |
Basic income per share attributable to CBRE Group, Inc. stockholders | $ | 1.18 |  |  | $ | 0.79 |  |  |  |  |
Diluted Income Per Share |  |  |  |  |  |  |
Net income attributable to CBRE Group, Inc. stockholders | $ | 392,297 |  |  | $ | 266,202 |  |  |  |  |
Weighted average shares outstanding for basic income per share | 331,925,104 |  |  | 335,860,494 |  |  |  |  |
Dilutive effect of contingently issuable shares | 5,215,221 |  |  | 3,720,010 |  |  |  |  |
Weighted average shares outstanding for diluted income per share | 337,140,325 |  |  | 339,580,504 |  |  |  |  |
Diluted income per share attributable to CBRE Group, Inc. stockholders | $ | 1.16 |  |  | $ | 0.78 |  |  |  |  |
For the three months ended March 31, 2022 and 2021, 1,349,842 and 481,341, respectively, of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect. In February 2019, our board of directors authorized a program for the repurchase of up to $300.0 million of our common stock over three years, effective March 11, 2019. In both August and November 2019, our board of directors authorized an additional $100.0 million under our program, bringing the total authorized repurchase amount under the program to a total of $500.0 million. During the year ended December 31, 2021, we repurchased 3,122,054 shares of our common stock with an average price of $92.03 per share using cash on hand for $287.3 million. During the three months ended March 31, 2022, we repurchased an additional 615,108 shares of our common stock with an average price of $101.88 per share using cash on hand for $62.7 million, fully utilizing the remaining capacity under this program. On November 19, 2021, our board of directors authorized a new program for the repurchase of up to $2.0 billion of our common stock over five years (the 2021 program). During the year ended December 31, 2021, we repurchased 832,315 shares of our common stock with an average price of $102.82 per share using cash on hand for $85.6 million. During the three months ended March 31, 2022, we repurchased an additional 3,563,278 shares of our common stock with an average price of $92.10 per share using cash on hand for $328.2 million. As of March 31, 2022, we had approximately $1.59 billion of capacity remaining under the 2021 program.

X
- Definition Earnings per share and stockholders' equity. + References No definition available. + Details
Name: | cbre_EarningsPerShareAndStockholdersEquityAbstract
Namespace Prefix: | cbre_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Earnings per share and stockholder's equity. + References No definition available. + Details
Name: | cbre_EarningsPerShareAndStockholdersEquityTextBlock
Namespace Prefix: | cbre_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration